E. Dadachova

MELANIN-TARGETING ANTIBODY AS A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY OF MELANOMA

M. Grmek

DOSE ASSESSMENT OF MEDICAL STAFF TAKING CARE OF PATIENTS TREATED WITH 131I DUE TO THE INTAKE OF 131I

A. Sevilla

IS EARLY STRONTIUM-89 THERAPY USEFUL IN PROSTATE CANCER PATIENTS WITH BONE METASTASIS?

Lj. Stefanovic

THE DISEASE RELATED DEATHS DUE TO DIFFERENTIATED THYROID CARCINOMAS TREATED MULTIDISCIPLINARY, INCLUDING RADIOIODINE

J.G. Tennvall

FDG-PET DURING THERAPY OF HEAD & NECK CARCINOMAS. PREDICTION OF TUMOR RESPONSE AND ASSOCIATIONS TO TUMOR CELL PROPERITIES

E. Urbanova

RETROSPECTIVE ANALYSIS OF CYSTIC CRANIOPHARYNGEOMAS AFTER INTRACAVITAL IRRADIATION WITH YTTRIUM-90 COLLOID

Y.L. Yu

131I TREATMENT OF SOFT TISSUE METASTASES FROM DIFFERENTIATED THYROID CARCINOMA

R.S. Zhu

THE CLINICAL SUMMARY OF 312 CASES OF DIFFERENTIATED THYROID CANCER METASTASES WITH 131I TREATMENT